logo
Plus   Neg
Share
Email

Shell Australia Says Welcomed Gas Sales Agreement Between Arrow And QCLNG

Shell Australia said it welcomed the gas sales agreement between Arrow and QCLNG - two separate joint ventures in which Shell participates.

Under the deal un-contracted gas from Arrow's Surat Basin fields would flow to the QCLNG project (involving Shell, CNOOC and Tokyo Gas) that would then sell gas to local customers and also export it through its gas plant on Curtis Island.

Shell chairman Zoe Yujnovich said the deal paved the way for a staged development of Arrow's world class gas resource.

Ms Yujnovich said QCLNG had existing pipelines, processing plants and had developed ways of supplying gas to both local and international customers - while Arrow had developed the expertise needed to extract gas from its fields in the Surat Basin.

"Onshore gas developed in Queensland has none of the oil produced by traditional gas fields, and is expensive to develop - so without the scale of LNG development it would simply stay in the ground", she said.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
eBay Inc. has filed a lawsuit against Amazon.com Inc., accusing its e-commerce rival of illegally poaching sellers on its marketplace by infiltrating eBay's internal messaging system. The lawsuit filed by eBay on Wednesday in Santa Clara County in California, accuses Amazon of having "perpetrated a scheme to infiltrate and exploit eBay's internal member email system" over the past several years. Philip Morris International Inc. (PM) announced, for the third-quarter, reported and adjusted diluted earnings per share was $1.44, up 13.4% versus $1.27 in 2017. Excluding unfavorable currency of $0.09, adjusted diluted earnings per share up by 20.5% to $1.53 from $1.27 in 2017. On average, 13 analysts... Shares of Novartis AG were gaining around 2 percent in the morning trading in Switzerland after the drug major on Thursday lifted its fiscal 2018 net sales guidance, despite weak profit in its third quarter. Core earnings topped analysts' estimates, while net sales missed their view, despite a growth. Further, Novartis announced an agreement to buy Endocyte, a US-based biopharmaceutical company.
Follow RTT